Ftse Mib
33.707,21
-0,38%
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
1,26%
Bitcoin
61.688,95
2,37%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Molecular Transport Inc (AMTI) Applied Molecular Transport Inc (AMTI) Notizie

AMTI

Applied Molecular Transp... (AMTI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMTI
DataOraFonteTitoloSimboloCompagnia
09/01/202412:12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMTIApplied Molecular Transport Inc
03/01/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415:15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415:14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202415:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202323:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/12/202322:15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.NASDAQ:AMTIApplied Molecular Transport Inc
27/12/202321:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202322:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMTIApplied Molecular Transport Inc
21/11/202315:16Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMTIApplied Molecular Transport Inc
09/11/202322:01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
27/09/202317:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AMTIApplied Molecular Transport Inc
21/09/202314:05Business WireCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementNASDAQ:AMTIApplied Molecular Transport Inc
14/08/202322:01GlobeNewswire Inc.Applied Molecular Transport Reports Second Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
15/06/202323:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
15/06/202322:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
08/06/202322:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMTIApplied Molecular Transport Inc
11/05/202322:05GlobeNewswire Inc.Applied Molecular Transport Reports First Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
28/04/202322:30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMTIApplied Molecular Transport Inc
27/03/202322:01GlobeNewswire Inc.Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic AlternativesNASDAQ:AMTIApplied Molecular Transport Inc
09/03/202322:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMTIApplied Molecular Transport Inc
09/03/202322:05GlobeNewswire Inc.Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
03/03/202314:00GlobeNewswire Inc.Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 CongressNASDAQ:AMTIApplied Molecular Transport Inc
09/02/202322:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMTIApplied Molecular Transport Inc
22/12/202223:30GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202215:10Dow Jones NewsApplied Molecular Transport Gets New FDA Orphan Drug DesignationNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202214:00GlobeNewswire Inc.Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of PouchitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202205:25TipRanksSVB Securities Remains a Buy on Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
08/11/202214:00GlobeNewswire Inc.Applied Molecular Transport to Present at Upcoming November Investor ConferencesNASDAQ:AMTIApplied Molecular Transport Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMTI

La tua Cronologia

CREX
TTNBTC
Titan Coin
EU
BPKM
BPCE 1% due 22dec2025
BOV
MBLY3F
Mobly ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network